Journal
ACTA PSYCHIATRICA SCANDINAVICA
Volume 139, Issue 4, Pages 348-360Publisher
WILEY
DOI: 10.1111/acps.13008
Keywords
schizophrenia; bipolar disorder; general population; cardiovascular risk; life expectancy
Categories
Funding
- Research Council of Norway [223273, 262656, 248828]
- K.B. Jebsen Stiftelsen [SKGJ-MED-008]
- South-East Norway Health Authority [2017-112]
- Novo Nordisk Foundation [NNF16OC0019856]
Ask authors/readers for more resources
Objective While CVD risk has decreased in the general population during the last decade, the situation in patients with schizophrenia (SCZ) and bipolar disorder (BD) is unknown. Methods We compared CVD risk factors in patients with SCZ and BD recruited from 2002-2005 (2005 sample, N = 270) with patients recruited from 2006-2017 (2017 sample, N = 1011) from the same catchment area in Norway. The 2017 sample was also compared with healthy controls (N = 922) and the general population (N range = 1285-4587, Statistics Norway) from the same area and period. Results Patients with SCZ and BD in the 2017 sample had significantly higher level of most CVD risk factors compared to healthy controls and the general population. There was no significant difference in the prevalence of CVD risk factors in SCZ between the 2005 and 2017 samples except a small increase in glucose in the 2017 sample. There were small-to-moderate reductions in hypertension, obesity, total cholesterol, low-density lipoprotein, systolic and diastolic blood pressure in the BD 2017 sample compared to the 2005 sample. Conclusion Despite major advances in health promotion during the past decade, there has been no reduction in the level of CVD risk factors in patients with SCZ and modest improvement in BD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available